Diabetic retinopathy group 7 period 2 #

358 views
290 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
358
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Diabetic retinopathy group 7 period 2 #

  1. 1. Diabetic RetinopathyBy: Steyn Funk, Renata Offen, Nathaly Merine, andAileen
  2. 2. Those who get affected… Are people who generally have long-term diabetes, and Type 1 and Type 2 Those who are Hispanic or African American have a greater risk of getting this disease Mostly found in adolescents and people over 30 years old It also affects both genders
  3. 3. What is retinopathy? Damage to the eye’s retina that occurs with long-term diabetes Symptoms include: blind spots, difficulty in vision in dim light, double vision, hazy or blurry focus, pain in the eye, headaches, floating spots, no peripheral vision, and shadows Possible complications include: cataracts, glaucoma, macular edema, retinal detachment.
  4. 4. Areas of infection Infects blood vessels in the eyes Blocks the blood vessel Small bleeding (or retinal hemorrhages) and fluid leaking into the retina. New blood vessels are fragile and can bleed Scars develop on retina and other parts of the eye (the vitreous)
  5. 5. The cause of infectionDiabetes Type 1 and 2Damage to blood vessels of retinaWhen you are diagnosed with Type 1 or 2diabetes you are more susceptible to infectionA person in adolescent or of more than 30 yearswith diabetes are at risk
  6. 6. TreatmentControl levels of blood sugar, blood pressure, andcholesterol, and refrain from tobacco useTreatment: focal laser photocoagulation is used totreat itScatter laser treatment or panretinal photocoagulationAlso surgical treatment called vitrectomyPerceptions include: corticosteroids
  7. 7. CitationA.D.A.M. MEDICAL ENCYCLOPEDIA. (2012, JANUARY 12).PUBMED HEALTH. RETRIEVED FROMHTTP://WWW.NCVI.NLM.NIH.GOV/PUBMENDHEALTH/PMH0002192/

×